L. Wilhelmsen et al., Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors, J INTERN M, 250(5), 2001, pp. 382-389
Citations number
24
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objectives. To analyse the incidence, prevalence, aetiology, risk factors a
nd prognosis of hospitalizations for atrial fibrillation.
Subjects. A random population sample of 7495 men aged 47-55 years was first
examined in 1970-73. During follow-up until 1996 (mean 25.2 years) 754 men
were hospitalized with a diagnosis of atrial fibrillation.
Results. In the age groups of 55-64, 65-74 and 75-79 years, the incidence r
ate was 2.0, 5.8 and 17.3 per 1000 person years, and the prevalence 1.2, 4.
2 and 8.0%, respectively. Definite or possible coronary heart disease was d
iagnosed in 46.0%, heart failure in further 20.2% and valvular heart diseas
e or cardiomyopathy in 4.5%. In bivariate analysis adjusted for age, the fo
llowing factors were significantly associated with future hospitalization f
or fibrillation: a family history of myocardial infarction, stroke in mothe
r, dyspnoea at entry. alcohol abuse, high body stature and body weight, hig
h blood pressure but not diabetes, high serum cholesterol, high heart rate,
smoking, coffee consumption or psychological stress. Significant risk fact
ors in multivariate analysis were age, odds ratio (OR) [95% confidence inte
rval(CI)]-1.11 (1.07, 1.16)per year. hospitalization for coronary heart dis
ease or heart failure -6.77 (5.17, 8.87), stroke in mother -1.49 (1.15, 1.9
3). high body stature -1.04 (1.03, 1.06) per cm, high body mass index (BMI)
-1.07 (1.04, 1.10) per kg m(-2), as well as hypertension -1.33 (1.07, 1.65
). After a diagnosis of atrial fibrillation, mortality was increased by 3.3
times.
Conclusion. In spite of a clinical association with coronary heart disease,
risk factors for atrial fibrillation were only partly the same. Prevention
includes avoidance of weight gain and control of blood pressure as well as
prevention of myocardial infarction and heart failure.